SEVALENT Trademark
Trademark Overview
On Thursday, September 8, 2022, a trademark application was filed for SEVALENT with the United States Patent and Trademark Office. The USPTO has given the SEVALENT trademark a serial number of 97583886. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, November 25, 2024. This trademark is owned by Bexson Biomedical, Inc.. The SEVALENT trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:
Pharmaceutical preparations for reducing, managing and relieving pain, treating addiction disorders and treating mental health illnesses; pharmaceutical preparations consisting of ketamine, flumazenil and psychedelics for the treatment of pain, addiction disorders and mental health illnesses; pharmaceutical preparations, namely, medicinal psychoactive psychedelic therapies for the treatment of pain, addiction disorders and mental health illnesses; drug delivery agents in the form of small molecules for the controlled release of therapeutic agents; wearable drug delivery devices, namely, subcutaneous pumps, sold filled with pharmaceutical preparations, for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnesses
providing business information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor
providing regulatory compliance information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor
providing medical information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor
Wearable drug delivery devices sold empty, namely, subcutaneous pumps for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnesses
Medical and scientific research in the fields of addiction disorders, mental health illnesses, pain management, reduction and relief; developing modular subcutaneous delivery platforms for small molecules for controlled delivery of therapeutic agents; medical and scientific research and development in relation to pharmaceuticals and drug delivery platforms; providing scientific information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor
General Information
| Serial Number | 97583886 |
| Word Mark | SEVALENT |
| Filing Date | Thursday, September 8, 2022 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, November 25, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 17, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for reducing, managing and relieving pain, treating addiction disorders and treating mental health illnesses; pharmaceutical preparations consisting of ketamine, flumazenil and psychedelics for the treatment of pain, addiction disorders and mental health illnesses; pharmaceutical preparations, namely, medicinal psychoactive psychedelic therapies for the treatment of pain, addiction disorders and mental health illnesses; drug delivery agents in the form of small molecules for the controlled release of therapeutic agents; wearable drug delivery devices, namely, subcutaneous pumps, sold filled with pharmaceutical preparations, for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnesses |
| Goods and Services | providing business information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor |
| Goods and Services | providing regulatory compliance information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor |
| Goods and Services | providing medical information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor |
| Goods and Services | Wearable drug delivery devices sold empty, namely, subcutaneous pumps for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnesses |
| Goods and Services | Medical and scientific research in the fields of addiction disorders, mental health illnesses, pain management, reduction and relief; developing modular subcutaneous delivery platforms for small molecules for controlled delivery of therapeutic agents; medical and scientific research and development in relation to pharmaceuticals and drug delivery platforms; providing scientific information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 26, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 26, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 11, 2023 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 26, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 11, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 11, 2023 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Bexson Biomedical, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Santa Barbara, CA 93108 |
Trademark Events
| Event Date | Event Description |
| Monday, September 12, 2022 | NEW APPLICATION ENTERED |
| Monday, September 26, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 22, 2023 | ASSIGNED TO EXAMINER |
| Thursday, June 22, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, June 22, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, June 22, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, July 10, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 10, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 11, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 12, 2023 | SUSPENSION LETTER WRITTEN |
| Wednesday, July 12, 2023 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, July 12, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, November 19, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, January 11, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
